The Dominican Republic Ministry of Health is using AI and machine learning technology from Israeli company Mobile ODT in a large-scale cervical-cancer screening project.

Femtech firm Mobile ODT’s Eva Visual Check AI technology is supporting the proof-of-concept project.

In the past three months, 9000 women have been screened for cervical cancer with the Eva Visual Check AI technology. Due to the initial success of the project, it was decided to expand this programme to cover another 50,000 women who are due to be screened over the next six months.

Visual Check provides non-specialists with an AI clinical decision support tool, predicting how highly trained colposcopists would determine positive or negative cervical-cancer diagnosis.

With a high cervical-cancer rate among the Dominican Republic population, early prevention can make a huge impact on women’s lives. Furthermore, it can help the health system save funds that would have been otherwise used for treatment.

“Many cervical-cancer cases happen due to a lack of timely follow-up,” said Alfredo Levy, one of the physicians involved in this project. “The ability to receive the results immediately at the point of care is a complete game changer. The Eva Visual Check system is quick and easy to use, allowing us to screen more patients, and predict results with a high accuracy.”

Visual Check AI is the first step in the company’s long-term strategy to develop AI that will transform the femtech market.

“We are the only company in the world with an AI capability in cervical-cancer screening,” said Leon Boston, Mobile ODT’s CEO. “Our unique AI algorithm, allows an unprecedented screening scale, that can be life saving for so many women around the world. We are currently in the midst of a funding round to support our long-term strategy and expand to broader areas in women’s health with AI technology.”

Mobile ODT helps clinicians use the power of AI on its portable medical devices to enhance women’s health. The Eva system combines imaging, data and software applications to expand access to quality care in over 20 countries and across more than 60 US health systems. The Eva smart mobile colposcope is used by clinicians worldwide for colposcopy, general gynaecology, tele-gynaecology and forensic imaging.

Mobile ODT is integrating its AI in approved markets to provide clinical decision support to healthcare providers at the point of care. The company has raised $26m to date from Orbimed, Tristel, Tara Health, Laerdal, DAI, private funds and investors